Log In
Print
BCIQ
Print
Print this Print this
 

LY2835219

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSelective dual inhibitor of cyclin dependent kinase 4 (CDK4) and CDK6
Molecular Target Cyclin dependent kinase 4 (CDK4) ; Cyclin dependent kinase 6 (CDK6)
Mechanism of ActionCyclin dependent kinase (CDK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today